Novalis II General Partner BV

Ottergemsesteenweg-Zuid 808 Bus B511

9000 Gent

BE

Novalis II General Partner BV

Foundation date

21/08/2017

Sector

#Investor

Subsector

Novalis Biotech seeds biotechnology and life sciences related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience and complementary skills.

Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of disease.

Novalis was founded by Prof. Wim Van Criekinge and Jan Van den Berghe.

As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences.

Upcoming events

Latest news

  • New way of twisting fibers improves energy storage in wearable devices

    4 hours ago

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    1 day ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    Wednesday November 20th 2024